G1 Therapeutics, Inc.
GTHXDelisted Sep 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001560241
G1 Therapeutics, Inc. was delisted on Sep 18, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 88 institutions reported holding it in 13F filings for Q2 2024, worth $45.5M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding G1 Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 80 | 2 | 72 | −6 |
| Shares | 15.5M | 459.1K | 10.9M | −4.09M (−27.2%) |
| Value | $38.6M | $1.14M | $15.8M | −$21.7M (−57.9%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held G1 Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 131,585 | $189.0K | 0.00% |
| Two Sigma Investments, LP | 90,400 | $130.2K | 0.00% |
| Algert Global LLC | 68,100 | $98.1K | 0.00% |
| Beacon Pointe Advisors, LLC | 43,000 | $61.9K | 0.00% |
| Cubist Systematic Strategies, LLC | 21,359 | $30.8K | 0.00% |
| Simplex Trading, LLC | 17,480 | $25.0K | 0.00% |
| Engineers Gate Manager LP | 14,358 | $20.7K | 0.00% |
| Squarepoint Ops LLC | 12,815 | $18.5K | 0.00% |
| Jane Street Group, LLC | 10,395 | $15.0K | 0.00% |
| Federated Hermes, Inc. | 3,274 | $4.71K | 0.00% |
| Northwestern Mutual Wealth Management Co | 1,000 | $1.44K | 0.00% |
Sold out (17)
Institutions that held G1 Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Fisher Asset Management, LLC | 2,543,006 | $6.33M |
| Woodline Partners LP | 150,437 | $374.6K |
| Occudo Quantitative Strategies LP | 112,793 | $280.9K |
| Jump Financial, LLC | 105,385 | $262.4K |
| AQR Capital Management LLC | 74,927 | $186.6K |
| Graham Capital Management, L.P. | 55,805 | $139.0K |
| UBS Asset Management Americas Inc | 39,600 | $106.1K |
| Allspring Global Investments Holdings, LLC | 31,443 | $78.3K |
| Laurion Capital Management LP | 26,655 | $66.4K |
| Y-Intercept (Hong Kong) Ltd | 22,855 | $56.9K |
| Schonfeld Strategic Advisors LLC | 17,400 | $43.3K |
| Financial Engines Advisors L.L.C. | 15,107 | $37.6K |
| Two Sigma Securities, LLC | 12,587 | $31.3K |
| Susquehanna International Group, LLP | 12,471 | $31.1K |
| Steward Partners Investment Advisory, LLC | 3,000 | $7.47K |
| Nisa Investment Advisors, LLC | 678 | $1.69K |
| ICA Group Wealth Management, LLC | 50 | $125 |
Not filed for Q3 2023 yet (2)
Institutions that held G1 Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 423,869 | $1.06M |
| BDO Wealth Advisors, LLC | 35,234 | $87.7K |